Researchers demonstrated heat-induced pyroelectricity in viruses
On Sept. 25, 2023, researchers at the University of California, Berkeley reported that engineered viruses also can generate…
-
-
RNA for the first time recovered from an extinct species
On Sept. 22, 2023, a new study showed the isolation and sequencing of more than a century-old RNA…
-
Biotechnology | HIV | NIH | Non-Profit Research | Therapeutics | Vaccine
Clinical trial of HIV vaccine began in United States and South Africa
On Sept. 20, 2023, the National Institutes of Health announced that a trial of a preventive HIV vaccine…
-
Newly discovered trigger of Parkinson’s upends common beliefs
On Sept. 15, 2023, a Northwestern Medicine study challenges a common belief in what triggers Parkinson’s disease. Degeneration…
-
National Institutes of Health clinical trial of universal flu vaccine candidate began
On Sept. 15, 2023, researchers at the National Institute of Allergy and Infectious Diseases (NIAID) announced they had…
-
Biotechnology | Disease | Therapeutics | WHO
WHO reported legionellosis deaths from Poland
On Sept. 14, 2023, the World Health Organization (WHO) reported that as of September 11, 2023, a total…
-
Northwestern received $50 million to study life sciences using mathematics
On Sept. 14, 2023, Northwestern University announced it had been awarded $50 million over five years from the…
-
Biotechnology | Disease | Medicine | NIH | Therapeutics
NIH awarded $50.3 million for ‘multi-omics’ research on human health and disease
On Sept. 12, 2023, the National Institutes of Health announced it was establishing the Multi-Omics for Health and…
-
Moderna received U.S. FDA approval for updated COVID-19 vaccine
On Sept. 11, 2023, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
-
Pfizer and BioNTech received U.S. FDA approval for 2023-2024 COVID-19 vaccine
On Sept. 11, 2023, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics | Women's Health
High levels of particulate air pollution associated with increased breast cancer incidence
On Sept. 11, 2023, researchers at the National Institutes of Health (NIH) reported that living in an area…
-
European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older
On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…
-
The Markey Cancer Center became an NCI-designated Comprehensive Cancer Center
On Sept. 6, 2023, the Markey Cancer Center (MCC) became Kentucky’s first and only National Cancer Institute (NCI)-Designated…
-
Moderna clinical trial data confirmed updated Covid-19 vaccine generated strong immune response against BA.2.86 variant
On Sept. 6, 2023, Moderna announced that clinical trial data from its research assay confirmed its updated COVID-19…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA Cleared 23andMe improved BRCA report for communities underrepresented in genetic testing
On Aug. 31, 2023, 23andMe, a leading human genetics and biopharmaceutical company, today announced the Company has received…
-
Results from single-dose psilocybin randomized clinical trial treatment for major depressive disorder published in JAMA
On Aug. 31, 2023, study results published in JAMA found that psilocybin treatment was associated with a clinically…
-
Emergents’ NARCAN Nasal Spray launched OTC making it possible for everyone to help save a life from an opioid overdose Emergency
On Aug. 30, 2023, Emergent BioSolutions announced NARCAN® Naloxone HCl Nasal Spray 4 mg will be available on shelves…
-
WHO initiative signed new licensing agreements on COVID-19 technologies
On Aug. 29, 2023, the COVID-19 Technology Access Pool (C-TAP), a multi-stakeholder partnership to facilitate sharing of intellectual…
-
MIT and two California universities received $50 million grant for Army research
On Aug. 27, 2003, The Institute for Collaborative Biotechnologies (ICB) announced it was funding a $50 million five…
-
CDC’s ACIP announced vaccines recommendation for 2023-24 seasonal influenza
On Aug. 25. 2023, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP)…
-
Eye cell atlas pinpoints where disease-causing genes are expressed, raising hope for inroads against blindness
On Aug. 25, 2023, Harvard’s Center for Brain Science announced the creation of an eye atlas that pinpoints…
-
U.S. FDA approved first biosimilar to treat Multiple Sclerosis
On Aug. 24, 2023, the U.S. Food and Drug Administration (FDA) approved Sandoz’s Tyruko (natalizumab-sztn), the first biosimilar…
-
NIAID-funded study traced evolution of Malaria drug resistance in East Africa
On Aug. 24, 2023, the National Institute of Allergy and Infectious Diseases (NIAID) reported that emerging resistance to…
-
City of Hope received $32 million grant to advance novel therapies
On Aug. 24, 2023, researchers at City of Hope announced were awarded $32.3 million from the California Institute…
-
Parkinson’s disease gene variant found in study of some people of African ancestry
On Aug. 23, 2023, a gene variant found almost exclusively in the genomes of people of African ancestry…
-
CDC reported risk assessment summary for SARS CoV-2 sublineage BA.2.86
On Aug. 23, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced 9 BA.2.86 variant sequences…
-
Scientists released the first complete sequence of a human Y chromosome
On Aug. 23. 2023, researchers co-led by University of California, Santa Cruz Assistant Professor of Biomolecular Engineering Karen…
-
Aspirin can help prevent a second heart attack, but most don’t take it
On Aug. 22, 2023, a study led by researchers at Washington University School of Medicine in St. Louis…
-
Project NextGen awarded over $1.4 billion to develop future of COVID-19 vaccines and therapeutics
On Aug. 22, 2023, the U.S. Department of Health and Human Services (HHS) announced it had awarded more…
-
Alberta Innovates invested $13.6 million to strengthen Alberta’s technology sector
On Aug. 22, 2023, Alberta Innovates announced that more than $13.6 million will go to 19 partners, across…
![European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older](https://lifesciencehistory.com/wp-content/uploads/2022/08/european_commission_logo-768x768.jpg){kind=logo}
